Regulation of breathing movements in fetal sheep by prostaglandin E2.
In fetal sheep, plasma prostaglandin (PG) E2 concentrations are high, and fetal breathing movements (FBM) occur intermittently, primarily during low-voltage fast electrocortical activity (LVFA). There is evidence suggesting that prostaglandins, specifically PGE2, may regulate FBM. To define the physiological role of PGE2 in regulation of FBM, we infused meclofenamate (0.9 mg X kg-1 X h-1), a prostaglandin synthetase inhibitor, into six fetal sheep to suppress endogenous prostaglandin production. Afterward, PGE2 was added in mean doses of 9, 18, 36, and 90 ng X kg-1 X min-1. Meclofenamate decreased PGE2 concentrations and increased FBM, especially during high-voltage slow electrocortical activity (HVSA). Addition of PGE2 reversed the effects of meclofenamate, increasing PGE2 concentrations and decreasing FBM, especially during HVSA. The response to PGE2 was dose dependent; the overall incidence of FBM and incidences of FBM during HVSA and LVFA were inversely correlated with both the infused PGE2 dose and the mean PGE2 concentration. At higher doses of PGE2, FBM occurred intermittently and only during LVFA; thus PGE2 infusion restored the physiological pattern of FBM. These results indicate that PGE2 regulates FBM by inhibiting FBM during HVSA.
Wallen
L D
LD
Murai
D T
DT
Clyman
R I
RI
Lee
C H
CH
Mauray
F E
FE
Kitterman
J A
JA
D000818:Animals; D002540:Cerebral Cortex / Q000502:physiology; D016861:Cyclooxygenase Inhibitors; D015232:Dinoprostone; D004594:Electrophysiology; D005333:Fetus / Q000187:drug effects / Q000502:physiology*; D008469:Meclofenamic Acid / Q000494:pharmacology; D011458:Prostaglandins E / Q000097:blood / Q000494:pharmacology / Q000502:physiology*; D012119:Respiration / Q000187:drug effects; D012756:Sheep
D016861:Cyclooxygenase Inhibitors; D011458:Prostaglandins E; D008469:Meclofenamic Acid; D015232:Dinoprostone